Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Sean McCarthy will participate on a panel titled "Specialty Pharma Play: Are We Near the End?" at the Bio International Convention in Atlanta, GA
News | 05. 21. 2009
